Normoxic ventilation after cardiac arrest reduces oxidation of brain lipids and improves neurological outcome

被引:164
作者
Liu, YB
Rosenthal, RE
Haywood, Y
Miljkovic-Lolic, M
Vanderhoek, JY
Fiskum, G [1 ]
机构
[1] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA
[2] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA
[3] George Washington Univ, Sch Med & Hlth Sci, Dept Emergency Med, Washington, DC 20037 USA
关键词
heart arrest; reperfusion; resuscitation; dogs;
D O I
10.1161/01.STR.29.8.1679
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Increasing evidence that oxidative stress contributes to delayed neuronal death after global cerebral ischemia has led to reconsideration of the prolonged use of 100% ventilatory O-2 following resuscitation from cardiac arrest. This study determined the temporal course of oxidation of brain fatty acyl groups in a clinically relevant canine model of cardiac arrest and resuscitation and tested the hypothesis that postischemic ventilation with 21% inspired O-2, rather than 100% O-2, results in reduced levels of oxidized brain lipids and decreased neurological impairment. Methods-Neurological deficit scoring and high performance liquid chromatography measurement of fatty acyl lipid oxidation were used in an established canine model using 10 minutes of cardiac arrest followed by resuscitation with different ventilatory oxygenation protocols and restoration of spontaneous circulation for 30 minutes to 24 hours. Results-Significant increases in frontal cortex lipid oxidation occurred after 10 minutes of cardiac arrest alone with no reperfusion and after reperfusion for 30 minutes, 2 hours, and 24 hours (relative total 235-nm absorbing peak areas=7.1+/-0.7 SE, 17.3+/-2.7, 14.2+/-3.2, 16/1+/-1.0, and 14.0+/-0.8, respectively; n=4, P<0.05). The predominant oxidized lipids were identified by gas chromatography/mass spectrometry as 13- and 9-hydroxyoctadecadienoic acids (13- and 9-HODE). Animals ventilated on 21% to 30% O-2 versus 100% O-2 for the first hour after resuscitation exhibited significantly lower levels of total and specific oxidized lipids in the frontal cortex (1.7+/-0.1 versus 3.12+/-0.78 mu g 13-HODE/g wet wt cortex., n=4 to 6, P<0.05) and lower neurological deficit scores (45.1+/-3.6 versus 58.3+/-3.8, n=9, P<0.05). Conclusions-With a clinically relevant canine model of 10 minutes of cardiac arrest, resuscitation with 21% versus 100% inspired O-2 resulted in lower levels of oxidized brain lipids and improved neurological outcome measured after 24 hours of reperfusion. This study casts further doubt on the appropriateness of present guidelines that recommend the indiscriminate use of 100% ventilatory O-2 for undefined periods during and after resuscitation from cardiac arrest.
引用
收藏
页码:1679 / 1686
页数:8
相关论文
共 42 条
[1]   Comparative effects of linoleic acid and linoleic acid hydroperoxide on growth and morphology of bovine retinal pigment epithelial cells in vitro [J].
Akeo, K ;
Hiramitsu, T ;
Kanda, T ;
Yorifuji, H ;
Okisaka, S .
CURRENT EYE RESEARCH, 1996, 15 (05) :467-476
[2]  
BABBS CF, 1986, AM J EMERG MED, V4, P414
[3]  
Baiping Lei, 1994, Stroke, V25, P147
[4]   CEREBRAL PRESERVATION DURING CARDIOPULMONARY RESUSCITATION [J].
BIRCHER, N ;
SAFAR, P .
CRITICAL CARE MEDICINE, 1985, 13 (03) :185-190
[5]  
DEKOK TMCM, 1994, CARCINOGENESIS, V15, P1399, DOI 10.1093/carcin/15.7.1399
[6]   METABOLISM OF THE LIPID-PEROXIDATION PRODUCT 4-HYDROXYNONENAL BY ISOLATED HEPATOCYTES AND BY LIVER CYTOSOLIC FRACTIONS [J].
ESTERBAUER, H ;
ZOLLNER, H ;
LANG, J .
BIOCHEMICAL JOURNAL, 1985, 228 (02) :363-373
[7]   EXCITOTOXICITY AND NEUROLOGICAL DISORDERS - INVOLVEMENT OF MEMBRANE PHOSPHOLIPIDS [J].
FAROOQUI, AA ;
HORROCKS, LA .
INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 36, 1994, 36 :267-323
[8]   AGE INFLUENCE ON OXIDATIVE EVENTS DURING BRAIN ISCHEMIA REPERFUSION [J].
FLOYD, RA ;
CARNEY, JM .
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1991, 12 (2-3) :155-177
[9]   5-HPETE is a potent inhibitor of neuronal Na+, K+-ATPase activity [J].
Foley, TD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (02) :374-376
[10]  
Hall E D, 1994, Adv Pharmacol, V28, P221, DOI 10.1016/S1054-3589(08)60497-4